LobbyingThoragenix Innovations lobbying by quarter
Thoragenix Innovations's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q1 2025; the issues it reports most are Defense and Medical/Disease Research/Clinical Labs.
Thoragenix Innovations
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $10K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Defense$80K · 6 reports
- Medical research and clinical labs$80K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Acorn Consulting | $160K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Acorn Consulting | $30K |
| 04/15for Q1 | Acorn Consulting | $30K |
| 01/13for Q4 2025 | Acorn Consulting | $30K |
| 25/10/20for Q3 2025 | Acorn Consulting | $30K |
| 25/07/11for Q2 2025 | Acorn Consulting | $30K |
| 25/04/08for Q1 2025 | Acorn Consulting | $10K |
| 25/04/08for Q1 2025 | Acorn Consulting | Under $5,000 |